A preclinical study evaluating INOLIFE’s needle-free injection system (INOJEX) with cannabidiol (CBD) for the treatment of neuropathic pain and associated anxiety-depressive symptoms in rats.

Chronic neuropathic pain affects millions of Canadians for which the government spends ~$6 billion a year on treatment. It is therefore imperative to find new therapies with few side effects and high therapeutic efficacy. This study will examine the therapeutic properties of cannabidiol (CBD), which is a non-intoxicating component of cannabis. Studies have shown that […]

Read More